{"id":809187,"date":"2025-02-05T09:13:56","date_gmt":"2025-02-05T14:13:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/"},"modified":"2025-02-05T09:13:56","modified_gmt":"2025-02-05T14:13:56","slug":"biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/","title":{"rendered":"BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n SAN RAFAEL, Calif.<\/span>
\n <\/span>, Feb. 5, 2025<\/span><\/span> \/PRNewswire\/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy<\/span>, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, February 19, 2025<\/span>, at 4:30 p.m. ET<\/span> to discuss fourth quarter and full-year 2024 financial results and provide a general business update.<\/p>\n

\n

\n
\n \"BioMarin
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n Dial-in Number<\/b>\u00a0
U.S. \/ Canada Dial-in Number: 800-715-9871
International Dial-in Number: 646-307-1963
Conference Call ID: 1878833<\/p>\n

U.S. \/ Canada Replay Dial-in Number: 800-770-2030
International Replay Dial-in Number: 609-800-9909
Playback ID: 1878833\u00a0<\/p>\n

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website,\u00a0https:\/\/investors.biomarin.com\/<\/a>. A replay of the call will be archived on the site for one week following the call.<\/p>\n

\n About BioMarin
<\/b>BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California<\/span>-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com<\/a>.\u00a0<\/p>\n

\n\n\n\n\n\n\n
\n

\n Contacts:<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Investors<\/span>\n <\/p>\n<\/td>\n

\n

\n Media<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Traci\u00a0<\/i>
\n McCart<\/i>y<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Marni Kottle<\/i>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n BioMarin Pharmaceutical Inc. <\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n \u00a0BioMarin Pharmaceutical Inc.<\/i><\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n (415) 455-7558 <\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n \u00a0(650) 374-2803<\/i><\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et-302368081.html<\/a><\/p>\n

SOURCE BioMarin Pharmaceutical Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire SAN RAFAEL, Calif. , Feb. 5, 2025 \/PRNewswire\/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, February 19, 2025, at 4:30 p.m. ET to discuss fourth quarter and full-year 2024 financial results and provide a general business update. Dial-in Number\u00a0U.S. \/ Canada Dial-in Number: 800-715-9871International Dial-in Number: 646-307-1963Conference Call ID: 1878833 U.S. \/ Canada Replay Dial-in Number: 800-770-2030International Replay Dial-in Number: 609-800-9909Playback ID: 1878833\u00a0 Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website,\u00a0https:\/\/investors.biomarin.com\/. A replay of the call will be archived on the site for one week following … <\/p>\n

Continue reading “BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-809187","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN RAFAEL, Calif. , Feb. 5, 2025 \/PRNewswire\/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, February 19, 2025, at 4:30 p.m. ET to discuss fourth quarter and full-year 2024 financial results and provide a general business update. Dial-in Number\u00a0U.S. \/ Canada Dial-in Number: 800-715-9871International Dial-in Number: 646-307-1963Conference Call ID: 1878833 U.S. \/ Canada Replay Dial-in Number: 800-770-2030International Replay Dial-in Number: 609-800-9909Playback ID: 1878833\u00a0 Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website,\u00a0https:\/\/investors.biomarin.com\/. A replay of the call will be archived on the site for one week following … Continue reading "BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T14:13:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/534018\/BioMarin_Pharmaceutical_Inc_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET\",\"datePublished\":\"2025-02-05T14:13:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\\\/\"},\"wordCount\":273,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/534018\\\/BioMarin_Pharmaceutical_Inc_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\\\/\",\"name\":\"BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/534018\\\/BioMarin_Pharmaceutical_Inc_Logo.jpg\",\"datePublished\":\"2025-02-05T14:13:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/534018\\\/BioMarin_Pharmaceutical_Inc_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/534018\\\/BioMarin_Pharmaceutical_Inc_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/","og_locale":"en_US","og_type":"article","og_title":"BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET - Market Newsdesk","og_description":"PR Newswire SAN RAFAEL, Calif. , Feb. 5, 2025 \/PRNewswire\/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, February 19, 2025, at 4:30 p.m. ET to discuss fourth quarter and full-year 2024 financial results and provide a general business update. Dial-in Number\u00a0U.S. \/ Canada Dial-in Number: 800-715-9871International Dial-in Number: 646-307-1963Conference Call ID: 1878833 U.S. \/ Canada Replay Dial-in Number: 800-770-2030International Replay Dial-in Number: 609-800-9909Playback ID: 1878833\u00a0 Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website,\u00a0https:\/\/investors.biomarin.com\/. A replay of the call will be archived on the site for one week following … Continue reading \"BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-05T14:13:56+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/534018\/BioMarin_Pharmaceutical_Inc_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET","datePublished":"2025-02-05T14:13:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/"},"wordCount":273,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/534018\/BioMarin_Pharmaceutical_Inc_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/","name":"BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/534018\/BioMarin_Pharmaceutical_Inc_Logo.jpg","datePublished":"2025-02-05T14:13:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/534018\/BioMarin_Pharmaceutical_Inc_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/534018\/BioMarin_Pharmaceutical_Inc_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-and-webcast-on-wednesday-february-19-2025-at-430pm-et\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/809187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=809187"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/809187\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=809187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=809187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=809187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}